Replies to post #57121 on Biotech Values

[BioSpecialist]

All comments are welcome

from Presentation :

Rapinyl (cancer Pain) Phase III – US, Jap,Registration -EU (peak sales 500 million US$

Sublinox (Insomnia) US-NDA in Jan 2008 (peak sales 350 million US$)

OX 17 (GERD) Phase III results in 1H 2008 US/EU (peak sales 1 billion US$)

BLX-NLA (Rhinitis) start Phase III in 1H 2008 (peak sales 300 million US$)

[BioSpecialist]

approval coming next week

http://www.emea.europa.eu/meetings/committee.htm